Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Pfizer Preparing New Viagra Ad; Early Test Of DTC Climate Under Crawford?

Executive Summary

Pfizer's approach to a new TV ad campaign for Viagra (sildenafil) could be an early test of the climate for direct-to-consumer advertising during the Crawford era at FDA

You may also be interested in...



Pfizer Supports Stronger FDA Oversight Of DTC Promotions

Pfizer supports stronger "external oversight" of direct-to-consumer advertising, CEO Hank McKinnell says in his recently released book A Call To Action: Taking Back Healthcare for Future Generations.

Pfizer Supports Stronger FDA Oversight Of DTC Promotions

Pfizer supports stronger "external oversight" of direct-to-consumer advertising, CEO Hank McKinnell says in his recently released book A Call To Action: Taking Back Healthcare for Future Generations.

FDA Challenges Four Rx Ads; TAP Decides To Suspend Prevacid TV Campaign

TAP's decision to suspend Prevacid TV commercials could be an early indication of a decline in broadcast advertising for pharmaceutical products

Related Content

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

PS045575

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel